NZ591793A - Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds - Google Patents
Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compoundsInfo
- Publication number
- NZ591793A NZ591793A NZ591793A NZ59179309A NZ591793A NZ 591793 A NZ591793 A NZ 591793A NZ 591793 A NZ591793 A NZ 591793A NZ 59179309 A NZ59179309 A NZ 59179309A NZ 591793 A NZ591793 A NZ 591793A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compounds
- methylmethanamine
- fluoropyridin
- pyrrol
- sulfonyl
- Prior art date
Links
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 2
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 2
- 230000035882 stress Effects 0.000 abstract 2
- 231100000397 ulcer Toxicity 0.000 abstract 2
- DPRWORPFTHSTIE-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(4-methoxypyridin-2-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound FC=1C(CNC)=CN(S(=O)(=O)C=2N=CC=C(OC)C=2)C=1C1=CC=CN=C1F DPRWORPFTHSTIE-UHFFFAOYSA-N 0.000 abstract 1
- JDCBSVKVFVIKHL-UHFFFAOYSA-N 1-[4-fluoro-5-(2-fluoropyridin-3-yl)-1-(4-methylpyridin-2-yl)sulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound FC=1C(CNC)=CN(S(=O)(=O)C=2N=CC=C(C)C=2)C=1C1=CC=CN=C1F JDCBSVKVFVIKHL-UHFFFAOYSA-N 0.000 abstract 1
- 208000023514 Barrett esophagus Diseases 0.000 abstract 1
- 208000023665 Barrett oesophagus Diseases 0.000 abstract 1
- 208000007882 Gastritis Diseases 0.000 abstract 1
- 206010017866 Gastritis haemorrhagic Diseases 0.000 abstract 1
- 206010020601 Hyperchlorhydria Diseases 0.000 abstract 1
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 206010042220 Stress ulcer Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 abstract 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000009858 acid secretion Effects 0.000 abstract 1
- 230000037328 acute stress Effects 0.000 abstract 1
- 208000000718 duodenal ulcer Diseases 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 208000017215 gastric mucosa-associated lymphoid tissue lymphoma Diseases 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 201000000052 gastrinoma Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 208000000689 peptic esophagitis Diseases 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008218851 | 2008-08-27 | ||
| JP2008269099 | 2008-10-17 | ||
| PCT/JP2009/065279 WO2010024451A1 (en) | 2008-08-27 | 2009-08-26 | Pyrrole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ591793A true NZ591793A (en) | 2012-11-30 |
Family
ID=41508823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ591793A NZ591793A (en) | 2008-08-27 | 2009-08-26 | Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds |
Country Status (38)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2735162C (en) * | 2008-08-27 | 2015-06-23 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| US20110229879A1 (en) * | 2010-03-19 | 2011-09-22 | University Of Rochester | Methods and compositions for nuclear staining |
| CN102452979B (zh) * | 2010-11-03 | 2015-04-01 | 天津药明康德新药开发有限公司 | 5-氟-3-吡啶磺酰氯的合成方法 |
| CN102863371B (zh) * | 2011-07-06 | 2016-04-13 | 中国科学院上海有机化学研究所 | 氟代二氢吡咯或氟代吡咯 |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| KR102206928B1 (ko) | 2012-06-27 | 2021-01-22 | 다케다 야쿠힌 고교 가부시키가이샤 | 염에 의해 안정화된 아민과 유기산의 액상 제제 |
| WO2014133059A1 (ja) * | 2013-02-28 | 2014-09-04 | 武田薬品工業株式会社 | スルホニルクロライド化合物の製造法 |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| KR102084185B1 (ko) | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
| CN105367550A (zh) * | 2014-08-11 | 2016-03-02 | 江苏柯菲平医药股份有限公司 | 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用 |
| UY36547A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| WO2017018473A1 (ja) | 2015-07-30 | 2017-02-02 | 武田薬品工業株式会社 | 錠剤 |
| TW201718514A (zh) | 2015-08-07 | 2017-06-01 | 拜耳作物科學股份有限公司 | 作為殺蟲劑之經２－（雜）芳基取代之稠合雜環衍生物 |
| CN106430006B (zh) * | 2016-08-18 | 2018-06-12 | 国网湖南省电力公司带电作业中心 | 配电线路移动式绝缘登高作业装置及方法 |
| CN108203430A (zh) * | 2016-12-16 | 2018-06-26 | 天地人和生物科技有限公司 | 一种新型可逆性质子泵抑制剂及其制备方法和用途 |
| EP3651735B1 (en) | 2017-07-10 | 2022-04-13 | Takeda Pharmaceutical Company Limited | Preparation comprising vonoprazan |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| CN113527536B (zh) * | 2020-04-21 | 2024-03-22 | 杭州德柯医疗科技有限公司 | 一种含氟多糖高分子化合物及其制备方法 |
| HUE070031T2 (hu) * | 2020-06-17 | 2025-05-28 | Ildong Pharmaceutical Co Ltd | Új savszekréciós inhibitor és alkalmazása |
| EP4074317A1 (en) | 2021-04-14 | 2022-10-19 | Bayer AG | Phosphorus derivatives as novel sos1 inhibitors |
| CN113620930B (zh) * | 2021-07-12 | 2022-08-16 | 南京烁慧医药科技有限公司 | 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用 |
| CN118401510A (zh) * | 2021-12-15 | 2024-07-26 | 日东制药株式会社 | 1-磺酰基吡咯衍生物的新颖盐类、其制备方法及包含其的药物组合物 |
| KR20240119083A (ko) * | 2021-12-15 | 2024-08-06 | 일동제약(주) | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20230102353A (ko) * | 2021-12-30 | 2023-07-07 | 주식회사 대웅제약 | 삼중음성유방암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2031514T3 (es) | 1986-08-29 | 1992-12-16 | Pfizer Inc. | 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas. |
| US5128366A (en) | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
| WO1992004025A1 (en) | 1990-08-31 | 1992-03-19 | Warner-Lambert Company | Amino acid analogs as cck antagonists |
| US5331006A (en) * | 1990-08-31 | 1994-07-19 | Warner-Lambert Company | Amino acid analogs as CCK antagonists |
| SK44894A3 (en) | 1991-10-18 | 1995-04-12 | Monsanto Co | Trisubstituted aromatic compounds, method of their preparation and fungicidal agents |
| MX9205392A (es) | 1991-10-29 | 1993-04-01 | Du Pont | Triazolcarbozamidas herbicidas y procedimiento para su obtencion. |
| JPH06135961A (ja) | 1992-10-23 | 1994-05-17 | Nippon Iyakuhin Kogyo Kk | 新規ジフェニルピロリルフラン誘導体 |
| US5286742A (en) * | 1992-11-03 | 1994-02-15 | American Cyanamid Company | Pyrrole thiocarboxamide insecticidal and acaricidal agents |
| US5480902A (en) * | 1993-08-31 | 1996-01-02 | American Cyanamid Company | Thienylpyrrole fungicidal agents |
| JPH08119936A (ja) | 1994-10-18 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | 複素環式誘導体 |
| JPH0930967A (ja) | 1995-07-17 | 1997-02-04 | Chugai Pharmaceut Co Ltd | 抗潰瘍剤 |
| CN1232451A (zh) | 1996-08-28 | 1999-10-20 | 普罗克特和甘保尔公司 | 取代的环状胺金属蛋白酶抑制剂 |
| CZ225699A3 (cs) | 1996-12-23 | 2000-09-13 | Du Pont Pharmaceuticals Company | Dusíkaté heteroaromatické sloučeniny jako inhibitory faktoru Xa |
| JPH11209344A (ja) | 1998-01-26 | 1999-08-03 | Kyowa Hakko Kogyo Co Ltd | 含窒素複素環化合物 |
| GB9817548D0 (en) * | 1998-08-12 | 1998-10-07 | Novartis Ag | Organic compounds |
| AU2825000A (en) | 1999-03-10 | 2000-09-28 | Shionogi & Co., Ltd. | Medicinal compositions with (2.2.1) and (3.1.1) bicycloskeleton antagonistic to both of pgd2/txa2 receptors |
| TW575561B (en) | 1999-03-25 | 2004-02-11 | Hoffmann La Roche | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives |
| AU3783100A (en) | 1999-06-14 | 2000-12-21 | Dow Agrosciences Llc | Substituted triazoles, imidazoles and pyrazoles as herbicides |
| ES2250196T3 (es) * | 1999-08-26 | 2006-04-16 | Aventis Pharmaceuticals Inc. | Aminoiminometil o aminometil dihidrobenzofuranos y benzopiranos sustituidos. |
| US6911468B2 (en) | 2000-05-22 | 2005-06-28 | Takeda Chemical Industries, Ltd. | Tyrosine phosphatase inhibitors |
| US6589978B2 (en) | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| GB0016453D0 (en) | 2000-07-04 | 2000-08-23 | Hoffmann La Roche | Pyrrole derivatives |
| US7544690B2 (en) | 2001-10-01 | 2009-06-09 | Taisho Pharmaceutical Co., Ltd. | MCH receptor antagonists |
| EP1442041A1 (en) | 2001-11-08 | 2004-08-04 | PHARMACIA & UPJOHN COMPANY | Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| CA2464314A1 (en) | 2001-11-22 | 2003-05-30 | Ciba Specialty Chemicals Holding Inc. | Pyrrole synthesis |
| AU2002367424A1 (en) | 2001-12-28 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Androgen receptor antagonists |
| WO2003068738A1 (en) | 2002-02-11 | 2003-08-21 | Neurocrine Biosciences, Inc. | Pyrrole derivatives as ligands of melanocortin receptors |
| AU2003209114A1 (en) | 2002-02-14 | 2003-09-04 | Wyeth | Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| TW200306191A (en) | 2002-02-22 | 2003-11-16 | Teijin Ltd | Pyrrolopyrimidine derivatives |
| US7754738B2 (en) | 2002-06-13 | 2010-07-13 | E.I. Du Pont De Nemours And Company | Pyrazole and pyrrole carboxamide insecticides |
| CA2495216A1 (en) * | 2002-08-12 | 2004-02-19 | Sugen, Inc. | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| JP2004315511A (ja) | 2003-03-31 | 2004-11-11 | Taisho Pharmaceut Co Ltd | Ｍｃｈ受容体アンタゴニスト |
| US7612064B2 (en) | 2003-05-26 | 2009-11-03 | Takeda Pharmaceutical Company Limited | Sulfopyrroles |
| EP1803709B1 (en) | 2004-09-30 | 2013-01-02 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
| EP1655284A1 (en) | 2004-10-26 | 2006-05-10 | Aponetics AG | 2-Phenylsulfopyrroles |
| AU2006285641A1 (en) * | 2005-08-30 | 2007-03-08 | Takeda Pharmaceutical Company Limited | 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| US8512761B2 (en) * | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
| WO2007114338A1 (ja) | 2006-03-31 | 2007-10-11 | Takeda Pharmaceutical Company Limited | 酸分泌抑制薬 |
| US8933105B2 (en) * | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| EP2190822B1 (en) | 2007-09-28 | 2014-12-31 | Takeda Pharmaceutical Company Limited | 5-membered heterocyclic compounds as proton pump inhibitors |
| US20090318429A1 (en) * | 2008-04-28 | 2009-12-24 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives |
| MY152749A (en) | 2008-05-16 | 2014-11-28 | Takeda California Inc | Pyrazole and fused pyrazole glucokinase activators |
| CA2735162C (en) * | 2008-08-27 | 2015-06-23 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
-
2009
- 2009-08-26 CA CA2735162A patent/CA2735162C/en not_active Expired - Fee Related
- 2009-08-26 ME MEP-2013-90A patent/ME01598B/me unknown
- 2009-08-26 KR KR1020117006779A patent/KR101629181B1/ko active Active
- 2009-08-26 EA EA201170384A patent/EA019741B1/ru not_active IP Right Cessation
- 2009-08-26 DK DK09788053.8T patent/DK2318390T3/da active
- 2009-08-26 PE PE2011000194A patent/PE20110300A1/es not_active Application Discontinuation
- 2009-08-26 US US12/547,778 patent/US8969387B2/en active Active
- 2009-08-26 BR BRPI0917705A patent/BRPI0917705A2/pt not_active IP Right Cessation
- 2009-08-26 NZ NZ591793A patent/NZ591793A/xx not_active IP Right Cessation
- 2009-08-26 JO JO2009322A patent/JO2871B1/en active
- 2009-08-26 MX MX2011001955A patent/MX2011001955A/es active IP Right Grant
- 2009-08-26 HR HRP20130653AT patent/HRP20130653T1/hr unknown
- 2009-08-26 PE PE2013002359A patent/PE20141174A1/es not_active Application Discontinuation
- 2009-08-26 TW TW98128638A patent/TWI473798B/zh not_active IP Right Cessation
- 2009-08-26 AU AU2009284867A patent/AU2009284867B2/en not_active Ceased
- 2009-08-26 RS RS20130319A patent/RS52872B/sr unknown
- 2009-08-26 ES ES09788053T patent/ES2423289T3/es active Active
- 2009-08-26 MY MYPI20110861 patent/MY152008A/en unknown
- 2009-08-26 UA UAA201103600A patent/UA105185C2/uk unknown
- 2009-08-26 US US13/061,078 patent/US8592597B2/en active Active
- 2009-08-26 GE GEAP200912153A patent/GEP20135786B/en unknown
- 2009-08-26 CN CN200980142371.0A patent/CN102197033B/zh active Active
- 2009-08-26 SI SI200930654T patent/SI2318390T1/sl unknown
- 2009-08-26 PL PL09788053T patent/PL2318390T3/pl unknown
- 2009-08-26 EP EP09788053.8A patent/EP2318390B1/en active Active
- 2009-08-26 PT PT97880538T patent/PT2318390E/pt unknown
- 2009-08-26 AR ARP090103278A patent/AR073136A1/es unknown
- 2009-08-26 UY UY0001032074A patent/UY32074A/es not_active Application Discontinuation
- 2009-08-26 WO PCT/JP2009/065279 patent/WO2010024451A1/en not_active Ceased
- 2009-08-26 JP JP2011508745A patent/JP5638515B2/ja active Active
-
2011
- 2011-02-21 IL IL211335A patent/IL211335A/en not_active IP Right Cessation
- 2011-02-24 CL CL2011000402A patent/CL2011000402A1/es unknown
- 2011-02-25 DO DO2011000061A patent/DOP2011000061A/es unknown
- 2011-03-08 ZA ZA2011/01774A patent/ZA201101774B/en unknown
- 2011-03-18 MA MA33715A patent/MA32647B1/fr unknown
- 2011-03-25 CR CR20110169A patent/CR20110169A/es unknown
- 2011-03-25 EC EC2011010912A patent/ECSP11010912A/es unknown
- 2011-03-25 CO CO11036583A patent/CO6321166A2/es active IP Right Grant
-
2013
- 2013-07-26 CY CY20131100636T patent/CY1114452T1/el unknown
- 2013-07-26 SM SM201300085T patent/SMT201300085B/xx unknown
- 2013-10-01 US US14/043,018 patent/US8993598B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ591793A (en) | Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds | |
| TW200732326A (en) | Chromane substituted benzimidazole derivatives | |
| ATE512969T1 (de) | Benzimidazolderivate als selektive säurepumpenhemmer | |
| FI4148050T3 (fi) | Uusi haponerityksen estäjä ja sen käyttö | |
| CY1114415T1 (el) | 1-ετεροκυκλυλσουλφονυλ, 2-αμινομεθυλ, 5-(ετερο-) αρυλ υποκατεστημενα 1-η-πυρρολιου παραγωγα ως αναστολεις εκκρισης οξεος | |
| CA2671369A1 (en) | Crystal of benzimidazole compound | |
| RU2015122126A (ru) | Производное пиррол сульфонамида, метод его получения и применение в медицине | |
| JP2012501296A5 (enExample) | ||
| NO20092464L (no) | Faste former av rasemisk ilaprazol | |
| EA200901601A1 (ru) | Производные пиридазинона | |
| JP2010520153A (ja) | ピロール化合物 | |
| NO20075809L (no) | DNA-PK inhibitorer | |
| ATE514415T1 (de) | Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide | |
| ATE442140T1 (de) | Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten | |
| NO20072764L (no) | Kromanderivater som er nyttige syrepumpeantagonister | |
| AR059903A1 (es) | Derivados de cromano | |
| ES2375298T3 (es) | Procedimiento para preparar derivados de sulfóxido sustituidos. | |
| PE20120618A1 (es) | Compuestos de pirazol como inhibidores de la bomba de protones | |
| EA201790453A2 (ru) | Новая соль присоединения кислоты 1-(5-(2,4-дифторфенил)-1-((3- фторфенил)сульфонил)-4-метокси-1h-пиррол-3-ил)-n-метилметанамина | |
| WO2007072142A3 (en) | Benzimidazole-5-carboxamide derivatives | |
| KR102648314B1 (ko) | 벤즈이미다졸 유도체 화합물 및 이의 용도 | |
| MXPA05008959A (es) | Polimorfos de inhibidores de proteina cinasa de 2-indolinona sustituidos con pirrolo. | |
| WO2005007107A3 (en) | Histamine and cck2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer | |
| WO2007026218A3 (en) | Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists | |
| NO20080866L (no) | Faststoff saltformer av pyrrol-substituert 2-indolinon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 AUG 2016 BY CPA GLOBAL Effective date: 20130711 |
|
| LAPS | Patent lapsed |